News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Daily News FDA Approves HeartMate 3 as Destination Therapy in Advanced HF Michael O'Riordan October 19, 2018
News Daily News High-Risk Medical Device Approval Process in Europe Inches Towards Transparency Michael O'Riordan July 20, 2018
News Daily News Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval Michael O'Riordan May 08, 2018
News Conference News ACC 2018 Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018